biosimilars

News

Stada CEO confirms company may be for sale

Rumours that German pharma Stada may be up for sale have been all but confirmed by the company's chief executive, who told a news agency that "exploratory talks" are takin

News

Samsung seeks 'interchangeable' label for Humira biosimilar

While there are already a number of biosimilars of AbbVie's big-selling Humira on the US market, so far, only one – Boehringer Ingelheim's

News

UK High Court bars generics trade body from VPAS talks

An attempt by the British Generic Manufacturers Association (BGMA) to get a seat at the negotiation table for the new Voluntary Scheme for Branded Medicines Pricing and Ac

News

RxPreferred to offer Humira biosimilar through Mark Cuban's ...

Pharmacy benefits manager (PBM) RxPreferred

News

Samsung Biologics scores $897 million CMO order with Pfizer

South Korean contract development and manufacturing organisation (CDMO) Samsung Biologics marks another contract milestone as the company announces two high-value deals totalling £897

News

Biosimilar uptake remains poor, but Sandoz has a plan

Sandoz is a major player in biosimilar medicines, so it’s no surprise that it is concerned about how slowly these drugs are making inroads against their brand-name equival

Stada CEO confirms company may be for sale

Samsung seeks 'interchangeable' label for Humira biosimilar

UK High Court bars generics trade body from VPAS talks

RxPreferred to offer Humira biosimilar through Mark Cuban's ...

Samsung Biologics scores $897 million CMO order with Pfizer

Biosimilar uptake remains poor, but Sandoz has a plan

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

biosimilars

Editor's Picks